Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroaki Kurihara

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Thescientificworldjournal|April 16, 2015
Theragnostic imaging using radiolabeled antibodies and tyrosine kinase inhibitorsMitsuyoshi Yoshimoto, Hiroaki Kurihara, Hirofumi Fujii
Journal of Magnetic Resonance Imaging : JMRI|July 12, 2002
Prediction of postoperative pulmonary function using perfusion magnetic resonance imaging of the lungTae Iwasawa, Kimihiko Saito, Nobuo Ogawa, et al.
Breast (Edinburgh, Scotland)|November 29, 2011
Sentinel lymph node biopsy using indigo carmine blue dye and the validity of '10% rule' and '4 nodes rule'Tomoya Nagao, Takayuki Kinoshita, Takashi Hojo, et al.
Annals of Nuclear Medicine|November 10, 2019
Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ earlyYayoi Yamamoto, Sachiyo Mitsunaga, Ayumi Horikawa, et al.
Radiation Oncology (London, England)|January 16, 2017
Relationship between the uptake of <sup>18</sup>F-borono-L-phenylalanine and L-[methyl-<sup>11</sup>C] methionine in head and neck tumors and normal organsYoshiaki Watanabe, Hiroaki Kurihara, Jun Itami, et al.
Japanese Journal of Clinical Oncology|March 5, 2020
Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphomaYasuji Miyakita, Makoto Ohno, Masamichi Takahashi, et al.
Cancer Management and Research|December 22, 2017
Can <sup>18</sup>F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumorsKazuo Nakagawa, Shoji Takahashi, Masahiro Endo, et al.
Annals of Nuclear Medicine|March 17, 2015
Draft guidelines regarding appropriate use of (131)I-MIBG radiotherapy for neuroendocrine tumors : Guideline Drafting Committee for Radiotherapy with (131)I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear MedicineSeigo Kinuya, Keiichiro Yoshinaga, Tetsuya Higuchi, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|October 28, 2015
[Draft guideline regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors Drafting Committee for Guideline of Radiotherapy with 131I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine]Seigo Kinuya, Keiichiro Yoshinaga, Tetsuya Higuchi, et al.
Breast Cancer (Tokyo, Japan)|June 15, 2011
Sentinel lymph node biopsy in breast cancer patients with previous breast augmentation surgeryTomoya Nagao, Takashi Hojo, Hiroaki Kurihara, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Thescientificworldjournal|April 16, 2015
Theragnostic imaging using radiolabeled antibodies and tyrosine kinase inhibitorsMitsuyoshi Yoshimoto, Hiroaki Kurihara, Hirofumi Fujii
Journal of Magnetic Resonance Imaging : JMRI|July 12, 2002
Prediction of postoperative pulmonary function using perfusion magnetic resonance imaging of the lungTae Iwasawa, Kimihiko Saito, Nobuo Ogawa, et al.
Breast (Edinburgh, Scotland)|November 29, 2011
Sentinel lymph node biopsy using indigo carmine blue dye and the validity of '10% rule' and '4 nodes rule'Tomoya Nagao, Takayuki Kinoshita, Takashi Hojo, et al.
Annals of Nuclear Medicine|November 10, 2019
Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ earlyYayoi Yamamoto, Sachiyo Mitsunaga, Ayumi Horikawa, et al.
Radiation Oncology (London, England)|January 16, 2017
Relationship between the uptake of <sup>18</sup>F-borono-L-phenylalanine and L-[methyl-<sup>11</sup>C] methionine in head and neck tumors and normal organsYoshiaki Watanabe, Hiroaki Kurihara, Jun Itami, et al.
Japanese Journal of Clinical Oncology|March 5, 2020
Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphomaYasuji Miyakita, Makoto Ohno, Masamichi Takahashi, et al.
Cancer Management and Research|December 22, 2017
Can <sup>18</sup>F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumorsKazuo Nakagawa, Shoji Takahashi, Masahiro Endo, et al.
Annals of Nuclear Medicine|March 17, 2015
Draft guidelines regarding appropriate use of (131)I-MIBG radiotherapy for neuroendocrine tumors : Guideline Drafting Committee for Radiotherapy with (131)I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear MedicineSeigo Kinuya, Keiichiro Yoshinaga, Tetsuya Higuchi, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|October 28, 2015
[Draft guideline regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors Drafting Committee for Guideline of Radiotherapy with 131I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine]Seigo Kinuya, Keiichiro Yoshinaga, Tetsuya Higuchi, et al.
Breast Cancer (Tokyo, Japan)|June 15, 2011
Sentinel lymph node biopsy in breast cancer patients with previous breast augmentation surgeryTomoya Nagao, Takashi Hojo, Hiroaki Kurihara, et al.
Pageof 6